Monica R. Thomas - 20 Mar 2024 Form 4 Insider Report for G1 Therapeutics, Inc.

Role
General Counsel
Signature
/s/ Monica Thomas
Issuer symbol
N/A
Transactions as of
20 Mar 2024
Net transactions value
$0
Form type
4
Filing time
22 Mar 2024, 16:10:31 UTC
Previous filing
08 Jan 2024
Next filing
24 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHX Common Stock Award $0 +37,500 +48% $0.000000 115,651 20 Mar 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award that vests 50% on March 20, 2025 and 50% on March 20, 2026, subject to the Reporting Person's continued service through each applicable vesting date.
F2 Each RSU represents a contingent right to receive one share of Issuer common stock.
F3 Represents (i) 176 shares of common stock; (ii) 50,000 RSUs from award granted on May 22, 2023; (iii) 27,975 RSUs from award granted on January 3, 2024; and (iv) 37,500 RSUs from award granted on March 20, 2024.